Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2

References

• Akcay A, Nguyen Q, Edelstein CL. (2009). Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009:137072. doi:10.1155/2009/137072
   PubMed Web of Science ®Google Scholar
• Artieda M, Cenarro A, Gañán A, et al. (2003). Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 23:1645–52
   PubMed Web of Science ®Google Scholar
• Aydogdu A, Tasci I, Tapan S, et al. (2012). Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity? Exp Clin Endocrinol Diabetes 120:261–5
   PubMed Web of Science ®Google Scholar
• Aziz M, Wissing ML, Naver KV, et al. (2014). Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40. Gynecol Endocrinol 30:311–15
   PubMed Web of Science ®Google Scholar
• Boot RG, Renkema GH, Verhoek M, et al. (1998). The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 273:25680–5
   PubMed Web of Science ®Google Scholar
• Boot RG, van Achterberg TA, van Aken BE, et al. (1999). Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19:687–94
   PubMed Web of Science ®Google Scholar
• Duran-Salgado MB, Rubio-Guerra AF. (2014). Diabetic nephropathy and inflammation. World J Diabetes 5:393–8
   PubMedGoogle Scholar
• Eleftheriadis T, Antoniadi G, Pissas G, et al. (2013). The renal endothelium in diabetic nephropathy. Ren Fail 35:592–9
   PubMed Web of Science ®Google Scholar
• Helger R, Rindfrey H, Hilgenfeldt J. (1974). [Direct estimation of creatinine in serum and in urine without deproteinization using a modified Jaffé method]. Z Klin Chem Klin Biochem 12:344–9
   PubMedGoogle Scholar
• Hollak CE, van Weely S, van Oers MH, Aerts JM. (1994). Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288–92
   PubMed Web of Science ®Google Scholar
• Hussain M, Wilson JB. (2013). New paralogues and revised time line in the expansion of the vertebrate GH18 family. J Mol Evol 76:240–60
   PubMed Web of Science ®Google Scholar
• Johansen JS. (2006). Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 53:172–209
   PubMed Web of Science ®Google Scholar
• Kanneganti M, Kamba A, Mizoguchi E. (2012). Role of chitotriosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol 5:1–9
   PubMedGoogle Scholar
• Kim HM, Lee BW, Song YM, et al. (2012). Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus. Cardiovasc Diabetol 11:84. doi:10.1155/2009/137072
   PubMed Web of Science ®Google Scholar
• Kolset SO, Reinholt FP, Jenssen T. (2012). Diabetic nephropathy and extracellular matrix. J Histochem Cytoche. 60:976–86
   PubMed Web of Science ®Google Scholar
• Kundak AA, Tascilar ME, Abaci A, et al. (2012). Serum chitotriosidase activity: is it a new inflammatory marker in obese children? J Pediatr Endocrinol Metab 25:63–7
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, et al. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–70
   PubMed Web of Science ®Google Scholar
• MacIsaac RJ, Ekinci EI, Jerums G. (2014). ‘Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'. Kidney Int 86:50–7
   PubMed Web of Science ®Google Scholar
• Miralles JM, Corrales JJ, Garcia-Diez LC, et al. (1982). N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes. Clin Chim Acta 121:373–8
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Tanabe K, Croker BP, et al. (2011). Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol 7:36–44
   PubMed Web of Science ®Google Scholar
• Nishikawa KC, Millis AJ. (2003). gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res 287:79–87
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. (2008). Oxidative stress and endothelium dysfunction in diabetes mellitus type 2. Pol Merkur Lekarski 25:120–3
   PubMedGoogle Scholar
• Polovina MM, Potpara TS. (2014). Endothelial dysfunction in metabolic and vascular disorders. Postgrad Med 126:38–53
   PubMed Web of Science ®Google Scholar
• Rathcke CN, Persson F, Tarnow L, et al. (2009). YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 32:323–8
   PubMed Web of Science ®Google Scholar
• Rathcke CN, Vestergaard H. (2006). YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 55:221–7
   PubMed Web of Science ®Google Scholar
• Recomendation of the Polish Society of Diabetology. (2012). Clinical guidelines for management of diabetes. Diabetol Klin 1:A1–54
   Google Scholar
• Riabov V, Gudima A, Wang N, et al. (2014). Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol 5:75. doi:10.3389/fphys.2014.00075
   PubMed Web of Science ®Google Scholar
• Røndbjerg AK, Omerovic E, Vestergaard H. (2011). YKL-40 levels are independently associated with albuminuria in type 2 diabetes. Cardiovasc Diabetol 10:54. doi: 10.1186/1475-2840-10-54
   PubMed Web of Science ®Google Scholar
• Roshan B, Stanton RC. (2013). A story of microalbuminuria and diabetic nephropathy. J Nephropathol 2:234–40
   PubMedGoogle Scholar
• Schosinsky KH, Vargas M, Luz Esquivel A, Chavarria MA. (1987). Simple spectrophotometric determination of urinary albumin by dye-binding with use of bromphenol blue. Clin Chem 33:223–26
   PubMed Web of Science ®Google Scholar
• Sonmez A, Haymana C, Tapan S, et al. (2010). Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine 37:455–9
   PubMed Web of Science ®Google Scholar
• Sun YM, Su Y, Li J, Wang LF. (2013). Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun 433:359–61
   PubMed Web of Science ®Google Scholar
• Tao H, Yang JJ, Shi KH, et al. (2014). The significance of YKL-40 protein in liver fibrosis. Inflamm Res 63:249–54
   PubMed Web of Science ®Google Scholar
• van Eijk M, van Roomen CP, Renkema GH, et al. (2005). Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 17:1505–12
   PubMed Web of Science ®Google Scholar
• Wiela-Hojeńska A, Orzechowska-Juzwenko K. (1999). N-acetyl-beta-d-glucosaminidase and its clinical significance. Pol Arch Med Wewn 101:359–66
   PubMedGoogle Scholar
• Yildiz BS, Barutcuoglu B, Alihanoglu YI, et al. (2013). Serum chitotriosidase activity in acute coronary syndrome. J Atheroscler Thromb 20:134–41
   PubMed Web of Science ®Google Scholar
• Żurawska-Płaksej E, Rorbach-Dolata A, Knapik-Kordecka M, Piwowar A. (in press). Increased chitotriosidase activity in plasma with diabetes type 2. Arch Med Sci
   Google Scholar